年龄校正D-二聚体cutoff诊断肺栓塞的成本效果分析
该研究用决策树比较疑似肺栓塞患者采用年龄校正D-二聚体cutoff与标准cutoff的成本效果,时间跨度为终身。
要点
- 年龄校正D-二聚体cutoff可减少CT肺动脉造影需求并安全排除肺栓塞
- 该策略QALY损失仅0.0001但平均节省33.4美元,属递减成本效果创新
核心结论
- 年龄校正D-二聚体cutoff导致临床不显著的QALY下降但显著降低成本,是具有成本节约潜力的递减成本效果创新。
研究设计与样本
- 决策树模型比较年龄校正D-二聚体cutoff与标准cutoff,纳入短期静脉血栓栓塞相关事件和长期并发症及其发病率/死亡率和成本。
- 概率来自已发表文献和ADJUST-PE研究,成本来自美国估算,时间跨度为终身,采用医疗系统视角。
主要发现
- 与标准cutoff相比,年龄校正cutoff损失0.0001质量调整生命年(QALY),平均成本降低33.4美元。
关键数值与推荐
- 年龄校正D-二聚体cutoff定义:50岁以下<500 ng/mL,50岁及以上<年龄×10 ng/mL。
临床怎么用
- 对疑似肺栓塞且验前概率非高的患者,采用年龄校正D-二聚体cutoff可在轻微QALY损失下显著节约医疗成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with suspected pulmonary embolism (PE) and a non-high pretest probability, the use of an age-adjusted D-dimer cutoff (AADD, <500 ng/mL up to 50 years, then <age × 10 ng/mL) was shown to further reduce the need for computed tomography pulmonary angiography while safely ruling out PE. Our objective was to evaluate its cost-effectiveness. METHODS: We created a decision tree to compare the use of the AADD with the standard D-dimer cutoff. The model included short-term venous thromboembolism-related events and long-term complications, their associated morbidity/mortality, and costs. Probabilities were derived from published literature and the ADJUST-PE study, and costs from US estimates. The time horizon was lifetime, with a health care system perspective. RESULTS: Using the AADD cutoff, compared with the standard cutoff, was associated with a loss of 0.0001 quality-adjusted life-years (QALY) and an average cost reduction of $33.4. The decremental cost-effectiveness ratio (DCER) was +$282 881/lost QALY (95% confidence interval from +$43 209/lost QALY to a dominant strategy). The probability that the use of the AADD cutoff was either dominant or gained >$200 000/lost QALY was 79.4%. In sensitivity analyses, the DCER became <+$200 000/lost QALY only if, among patients with D-dimer below the AADD cutoff, the mortality of an undiagnosed PE was >6% or the prevalence of PE was >0.6%. CONCLUSIONS: The AADD cutoff results in a clinically nonsignificant decrease in QALY but important costs reductions. It is a decrementally cost-effective innovation, with a potential of cost savings of >$80 million per year for the United States health care system.
引用
- Blondon M, Le Gal G, Meyer G, et al. Age-adjusted D-dimer cutoff for the diagnosis of pulmonary embolism: A cost-effectiveness analysis. J Thromb Haemost. 2020. PMID: 31925875. doi:10.1111/jth.14733
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。